Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.
Pérez MS, Rodríguez-Capitán J, Requena-Ibáñez JA, Santos-Gallego CG, Urooj Zafar M, Escolar G, Mancini D, Mitter S, Lam D, Contreras JP, Fergus I, Atallah-Lajam F, Abascal V, Lala A, Moreno P, Moss N, Lerakis S, Sanz J, Fuster V, Badimon JJ. Pérez MS, et al. Among authors: fuster v. Cardiovasc Drugs Ther. 2023 Jun 15. doi: 10.1007/s10557-023-07469-6. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37318685
Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction.
Santos-Gallego CG, Requena-Ibáñez JA, Picatoste B, Fardman B, Ishikawa K, Mazurek R, Pieper M, Sartori S, Rodriguez-Capitán J, Fuster V, Badimon JJ. Santos-Gallego CG, et al. Among authors: fuster v. Circ Cardiovasc Imaging. 2023 Apr;16(4):e015298. doi: 10.1161/CIRCIMAGING.123.015298. Epub 2023 Apr 12. Circ Cardiovasc Imaging. 2023. PMID: 37042253
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure.
Angermann CE, Santos-Gallego CG, Requena-Ibanez JA, Sehner S, Zeller T, Gerhardt LMS, Maack C, Sanz J, Frantz S, Fuster V, Ertl G, Badimon JJ. Angermann CE, et al. Among authors: fuster v. Nat Cardiovasc Res. 2023 Nov;2(11):1032-1043. doi: 10.1038/s44161-023-00352-5. Epub 2023 Oct 26. Nat Cardiovasc Res. 2023. PMID: 39196095 Free PMC article. Clinical Trial.
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis.
Devesa A, Fuster V, Vazirani R, García-Lunar I, Oliva B, España S, Moreno-Arciniegas A, Sanz J, Perez-Herreras C, Bueno H, Lara-Pezzi E, García-Alvarez A, de Vega VM, Fernández-Friera L, Trivieri MG, Fernández-Ortiz A, Rossello X, Sanchez-Gonzalez J, Ibanez B. Devesa A, et al. Among authors: fuster v. Diabetes Care. 2023 Nov 1;46(11):2050-2057. doi: 10.2337/dc23-0871. Diabetes Care. 2023. PMID: 37713581 Free PMC article.
Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults.
Fernández-Friera L, García-Alvarez A, Oliva B, García-Lunar I, García I, Moreno-Arciniegas A, Gómez-Talavera S, Pérez-Herreras C, Sánchez-González J, de Vega VM, Rossello X, Bueno H, Fernández-Ortiz A, Ibañez B, Sanz J, Fuster V. Fernández-Friera L, et al. Among authors: fuster v. Eur Heart J Cardiovasc Imaging. 2024 Jun 28;25(7):968-975. doi: 10.1093/ehjci/jeae044. Eur Heart J Cardiovasc Imaging. 2024. PMID: 38426763 Free PMC article.
Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors.
Devesa A, Fuster V, García-Lunar I, Oliva B, García-Alvarez A, Moreno-Arciniegas A, Vazirani R, Pérez-Herreras C, Marina P, Bueno H, Fernández-Friera L, Fernández-Ortiz A, Sanchez-Gonzalez J, Ibanez B. Devesa A, et al. Among authors: fuster v. JACC Cardiovasc Imaging. 2025 Jan;18(1):48-58. doi: 10.1016/j.jcmg.2024.08.002. Epub 2024 Sep 11. JACC Cardiovasc Imaging. 2025. PMID: 39269413 Free article.
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial.
García-Álvarez A, Blanco I, García-Lunar I, Jordà P, Rodriguez-Arias JJ, Fernández-Friera L, Zegri I, Nuche J, Gomez-Bueno M, Prat S, Pujadas S, Sole-Gonzalez E, Garcia-Cossio MD, Rivas M, Torrecilla E, Pereda D, Sanchez J, García-Pavía P, Segovia-Cubero J, Delgado JF, Mirabet S, Fuster V, Barberá JA, Ibañez B; SPHERE-HF Investigators. García-Álvarez A, et al. Among authors: fuster v. Eur J Heart Fail. 2023 Mar;25(3):373-385. doi: 10.1002/ejhf.2745. Epub 2022 Dec 4. Eur J Heart Fail. 2023. PMID: 36404400 Free article. Clinical Trial.
Magnetic resonance imaging reference values for cardiac morphology, function and tissue composition in adolescents.
Real C, Párraga R, Pizarro G, García-Lunar I, González-Calvo E, Martínez-Gómez J, Sánchez-González J, Sampedro P, Sanmamed I, De Miguel M, De Cos-Gandoy A, Bodega P, Ibanez B, Santos-Beneit G, Fuster V, Fernández-Jiménez R. Real C, et al. Among authors: fuster v. EClinicalMedicine. 2023 Mar 3;57:101885. doi: 10.1016/j.eclinm.2023.101885. eCollection 2023 Mar. EClinicalMedicine. 2023. PMID: 37064511 Free PMC article.
Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis.
Iglesies-Grau J, Garcia-Alvarez A, Oliva B, Mendieta G, García-Lunar I, Fuster JJ, Devesa A, Pérez-Herreras C, Fernández-Ortiz A, Brugada R, Ibanez B, Fernandez-Jimenez R, Fuster V. Iglesies-Grau J, et al. Among authors: fuster jj, fuster v. Cardiovasc Diabetol. 2023 Dec 19;22(1):350. doi: 10.1186/s12933-023-02090-1. Cardiovasc Diabetol. 2023. PMID: 38115031 Free PMC article.
1,591 results